Strata Critical Medical (SRTA): Third Point LLC disclosed a 5.8% stake in SRTA and may seek to influence the company 5.8%

5.8%

Stake

5.13M

Shares owned

Stake as of

Oct 13, 2026

Filed

Oct 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

What came next

1. Oct 15, 20265% stakeThird Point LLC filed an activist stake (13D) of 5.8%
2. Nov 3, 2026Company filing · Form 8-K · ResultsReported its results
3. Nov 5, 2026Insider · First insider buy since Jun 2024Director purchased ~$10K of SRTA shares in the open market

How to read SEC Schedule 13D

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Strata Critical Medical

For Strata Critical Medical, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SRTA page.

How this filing works

• Schedule 13D vs 13G

Other disclosures at Strata Critical Medical

• SEC Form 13F-HRNov 13, 2026
• SEC Form 4Nov 9, 2026
• SEC Form 144Oct 2, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 12, 2026
• SEC Form 13F-HRFeb 11, 2026

Everything OQRO holds on this company is on its SRTA page.